Women with early, surgically-induced menopause had greater incidence of neurological problems, including declining cognitive function and early indicators of Alzheimer’s disease in a study reported at the American Academy of Neurology meeting.
Women with early, surgically-induced menopause had greater incidence of neurological problems, including declining cognitive function and early indicators of Alzheimer’s disease, according to a report at the American Academy of Neurology’s Annual Meeting.
Compared with women who had normal menopause, a young age at surgically-induced menopause was significantly associated with decline in memory; cognition; Alzheimer’s pathology; and neuritic plaques, which, in large numbers, are characteristic of Alzheimer’s disease. No significant association with Alzhemier’s disease itself was shown, however.
Lead author Riley Bove, MD, of Harvard Medical School, noted that estrogen is neuroprotective and that the loss of estrogen at an early age may “increase the risk of cognitive decline.”
Hormone replacement therapy (HRT) had no significant effect on cognitive decline, regardless of the duration of use or time of initiation.
Bove R, et al "Early surgical menopause is associated with a spectrum of cognitive decline" AAN 2013; Abstract IN8-2.004.
Link between reproductive life span and postmenopausal muscle mass
November 30th 2023A recent study in Menopause, the journal of The Menopause Society, suggests that a longer reproductive life span and later age at menopause may be associated with a reduced risk of low handgrip strength in postmenopausal women.
Read More
Exogenous hormones and patients at increased risk for breast cancer
October 17th 2023This lecture, presented by Holly J. Pederson, MD, at The Menopause Society 2023 Annual Meeting, looked at combined oral contraceptives in BRCA carriers and other high-risk patients, and hormone therapy in postmenopausal gene carriers as well as other high-risk women.
Read More